Sections
Gastroenterology
Biography
Dr. Lew, MD is a practicing Gastroenterologist in Jamaica Plain, MA. Dr. Lew graduated from New York University School of Medicine in 1992 and has been in practice for 26 years. He completed a residency at UCLA Medical Center. Dr. Lew also specializes in Internal Medicine.
Education
MD, New York University School of Medicine
MPH, Yale University School of Medicine
BS, Columbia University
Publications
Huang Q, Lew E, Cheng Y, Shinagare S, Deshpande V, Gold JS, Wiener D, Weber HC. Esophageal adenocarcinoma heterogeneity in clinicopathology and prognosis: A single center longitudinal study of 146 cases over a 20-year period. Ann Diagn Pathol. 2024 Jun; 70:152285. PMID: 38518703.
Published on 2/27/2024Huang Q, Lew E, Cheng Y, Huang K, Deshpande V, Shinagare S, Yuan X, Gold JS, Wiener D, Weber HC. Prognostic factors in clinicopathology of oesophagogastric adenocarcinoma: a single-centre longitudinal study of 347 cases over a 20-year period. Pathology. 2024 Jun; 56(4):484-492. PMID: 38480051.
Published on 5/5/2023Huang Q, Cheng Y, Lew E, Shi J, Wiener D, Weber HC. Patients with esophageal adenocarcinoma showed better prognosis than those with adenocarcinoma of the gastroesophageal junction. J Dig Dis. 2023 Feb; 24(2):98-112. PMID: 36970757.
Published on 10/1/2004Fang M, Lew E, Klein M, Sebo T, Su Y, Goyal R. DNA abnormalities as marker of risk for progression of Barrett's esophagus to adenocarcinoma: image cytometric DNA analysis in formalin-fixed tissues. Am J Gastroenterol. 2004 Oct; 99(10):1887-94. PMID: 15447746.
Published on 3/1/2004Lew EA. Clarithromycin, lansoprazole, and metronidazole eradicated Helicobacter pylori infection in chronic renal insufficiency. ACP J Club. 2004 Mar-Apr; 140(2):40. PMID: 15122860.
Published on 4/17/2003Lew EA, Stoffel EM. Natalizumab for active Crohn's disease. N Engl J Med. 2003 Apr 17; 348(16):1599; author reply 1599. PMID: 12700383.
Published on 12/1/2001Metz DC, Forsmark C, Lew EA, Starr JA, Soffer EF, Bochenek W, Pisegna JR. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am J Gastroenterol. 2001 Dec; 96(12):3274-80. PMID: 11774936.
Published on 7/1/2001Lew EA, Goyal RK. The enigma of short-segment Barrett's esophagus. Indian J Gastroenterol. 2001 Jul-Aug; 20(4):130-1. PMID: 11497168.
Published on 4/1/2000Lew EA, Pisegna JR, Starr JA, Soffer EF, Forsmark C, Modlin IM, Walsh JH, Beg M, Bochenek W, Metz DC. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Gastroenterology. 2000 Apr; 118(4):696-704. PMID: 10734021.
Published on 10/1/1999Lew EA. Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Aliment Pharmacol Ther. 1999 Oct; 13 Suppl 5:11-6. PMID: 10555604.